
SineuGene Therapeutics
Biopharmaceutical company specializing in gene therapy for brain disorders, leveraging research from Tsinghua University's School of Medicine, and focusing on new AAV capsid variations for CNS gene delivery.
Employees
Enterprise value
$55—83m
Authorizing premium user...